SCHEMBL30964359

SCHEMBL30964359

Oc1ncc(-c2ccc3ncnc(N4CCc5ccc(Cl)cc54)c3c2)cn1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
EGFR P00533 3/20 0.45
CSF1R P07333 1/20 0.41
HTT P42858 1/20 0.39
CYP3A4 P08684 10/20 0.39
CLK4 Q9HAZ1 9/20 0.39
CYP1A2 P05177 9/20 0.39
ALDH1A1 P00352 6/20 0.39
HIF1A Q16665 6/20 0.39
CYP2D6 P10635 5/20 0.39
LMNA P02545 5/20 0.39
USP2 O75604 5/20 0.39
MAPK1 P28482 4/20 0.39
CYP2C19 P33261 4/20 0.39
MEN1 O00255 3/20 0.39
KMT2A Q03164 3/20 0.39
TSHR P16473 1/20 0.39
HSD17B10 Q99714 1/20 0.39
ALOX15 P16050 1/20 0.39
MAP4K4 O95819 2/20 0.38
AKT1 P31749 2/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30964508 0.91 EGFR (0.44) EGFRCSF1RHTTCYP3A4CLK4
SCHEMBL30964408 0.91 EGFR (0.43) EGFRCSF1RHTTCYP3A4CLK4
SCHEMBL30964485 0.87 IRAK4 (0.44) EGFRCSF1RHTTCYP3A4CLK4
SCHEMBL4352943 0.86 EGFR (0.48) EGFRCSF1RHTTCYP3A4CLK4
SCHEMBL30964351 0.82 EGFR (0.41) EGFRCSF1RHTTCYP3A4CLK4
SCHEMBL30964454 0.82 AKT1 (0.42) EGFRCSF1RHTTCYP3A4CLK4
SCHEMBL30964500 0.82 EGFR (0.51) EGFRCSF1RCYP3A4CLK4CYP1A2
SCHEMBL30964394 0.82 EGFR (0.40) EGFRCSF1RHTTCYP3A4CLK4
SCHEMBL30964479 0.82 EGFR (0.50) EGFRCSF1RCYP3A4CLK4CYP1A2
SCHEMBL30964368 0.82 EGFR (0.39) EGFRCSF1RHTTCYP3A4CLK4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4605089-A1 COMPOUNDS USEFUL IN MODULATING EGFR AND PI3K Mekanistic Therapeutics LLC (US) 2025-08-27 EP disclosed
WO-2024086296-A1 COMPOUNDS USEFUL IN MODULATING EGFR AND PI3K MEKANISTIC THERAPEUTICS LLC (US) 2024-04-25 WO disclosed